D
BioNTech SE BNTX
$96.81 $4.044.36% NASDAQ
Recommendation
Prev Close
$92.77
Volume
507,909
Avg Vol (90D)
985,776
Market Cap
$22.30B
Dividend & Yield
--
52-Week Range
$76.53 - $131.49
P/E (TTM)
--
EPS (TTM)
-$3.40
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Fred Alger Management LLC Sells 35,467 Shares of BioNTech SE (NASDAQ:BNTX)
5/10/2025 - MarketBeat
Raymond James Financial Inc. Buys Shares of 5,122 BioNTech SE (NASDAQ:BNTX)
5/10/2025 - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price
5/8/2025 - MarketBeat
Fred Alger Management LLC Sells 35,467 Shares of BioNTech SE (NASDAQ:BNTX)
5/8/2025 - Ticker Report
BioNTech SE American Depositary Share (BNTX, $92.8) price exceeded its 50-day Moving Average on May 07, 2025
5/8/2025 - Tickeron - Technical Analysis
BioNTech (NASDAQ:BNTX) Issues Quarterly Earnings Results
5/7/2025 - MarketBeat
BioNTech SE American Depositary Share (BNTX, $101.1) Moving Average Convergence Divergence (MACD) Histogram turned negative on May 6, 2025
5/7/2025 - Tickeron - Stocks
Analysts Conflicted on These Healthcare Names: Immutep Ltd (OtherPRRUF), Organon (OGN) and BioNTech SE (BNTX)
5/7/2025 - TipRanks Financial Blog
BioNTech SE (BNTX) Gets a Buy from Evercore ISI
5/7/2025 - TipRanks Financial Blog
Why BioNTech Stock Got Trounced on Tuesday
5/6/2025 - Fool.com Headlines
Baker BROS. Advisors LP Invests $5.13 Million in BioNTech SE (NASDAQ:BNTX)
5/6/2025 - MarketBeat
BioNTech First Quarter 2025 Earnings: Beats Expectations
5/6/2025 - Simply Wall St
BioNTech SE American Depositary Share (BNTX, $101.1) price exceeded its 50-day Moving Average on May 05, 2025
5/6/2025 - Tickeron - Technical Analysis
BioNTech SE (BNTX) Q1 2025 Earnings Call Highlights: Navigating Challenges and Advancing ...
5/6/2025 - GuruFocus
Q1 2025 Biontech SE Earnings Call Transcript
5/6/2025 - GuruFocus
BioNTech SE Reports Q1 2025 Financial Results
5/6/2025 - TipRanks Financial Blog
BioNTech's Earnings Call: Oncology Progress Amid Financial Challenges
5/6/2025 - TipRanks Financial Blog
Jefferies Remains a Buy on BioNTech SE (BNTX)
5/5/2025 - TipRanks Financial Blog
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), PTC Therapeutics (PTCT) and Larimar Therapeutics (LRMR)
5/5/2025 - TipRanks Financial Blog
BioNTech SE (BNTX) Q1 2025 Earnings Call Transcript
5/5/2025 - Seeking Alpha: Transcripts
BioNTech SE (BNTX) Q1 2025 Earnings Call Transcript
5/5/2025 - SeekingAlpha
BioNTech SE 2025 Q1 - Results - Earnings Call Presentation
5/5/2025 - SeekingAlpha
BioNTech SE (BNTX) Reports Q1 2025 Financial Results and Strategic Updates BNTX stock news
5/5/2025 - GuruFocus
BioNTech SE Appoints New CFO to Drive Financial Strategy in Oncology Expansion BNTX stock news
5/5/2025 - GuruFocus
BioNTech Reports Q1 2025 Financial Results and Strategic Oncology Advancements
5/5/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$2.97B
EBITDA (TTM)
-$1.09B
EBIT (TTM)
-$1.36B
Net Income (TTM)
-$812.62M
Balance Sheet
Total Assets (Q)
$22.89B
Total Debt (Q)
$316.69M
Total Liabilities (Q)
$2.44B
Book Value Per Share (Q)
$85.10
Cash Flow
Cash from Operations (TTM)
-$266.41M
Cash from Investing (TTM)
$1.54B
Cash from Financing (TTM)
-$55.64M
Net Change in Cash (TTM)
$1.27B
Filings
Filing Date
Monday, May 5, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
0.85
7-Day Total Return
-5.55%
30-Day Total Return
1.90%
60-Day Total Return
-21.20%
90-Day Total Return
-14.06%
Year to Date Total Return
-16.09%
1-Year Total Return
5.54%
2-Year Total Return
-5.70%
3-Year Total Return
-32.36%
5-Year Total Return
95.45%
52-week Low
Aug 05, 2024 - $76.53
52-week High
Sep 17, 2024 - $131.49
Valuation
Market Cap
$22.30B - Large Cap
Enterprise Value
$7.37B
Price/Sales (TTM)
7.51
Price/Book (Q)
1.09
Dividends and Shares
Shares Outstanding
240.35M
Dividend Per Share (Most Recent)
$1.55
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biontech.de
Phone Number
49 6131 9084
Address
An der Goldgrube 12
Mainz, 55131
Country
Germany
Year Founded
2008
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical... more
NASDAQ 05/12/2025 2:04PM Eastern Quotes delayed